Guaifenesin: Clinical Trials

3 trials of Guaifenesin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Guaifenesin: new trials by email Literature Review of Guaifenesin trials Research Report on Guaifenesin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
Guaifenesin, Placebo - Acute Upper Respiratory Track Infection
Phase 4CompletedReckitt Benckiser Inc.11792009-10-012020-12-30
Phase 4 Study - Mucinex D as Adjunct Therapy
Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets) - Acute Respiratory Infection, Bronchitis
Phase 4CompletedAdams Respiratory Therapeutics6002007-02-012008-02-06
Treatment of Acute Sinusitis
Acetaminophen, Amoxicillin, Dextromethorphan hydrobromide with guaifenesin - Acute Respiratory Infections, Acute Rhinosinusitis
Phase 4CompletedWashington University School of Medicine1722006-10-012012-12-28

Conditions studied

Rhinosinusitis (2)  ·  Bronchitis (1)  ·  Sinusitis (1)

Sponsors

Adams Respiratory Therapeutics (1)  ·  Reckitt Benckiser Inc. (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)

Top investigators

Helmut Albrecht, M.D. (1)  ·  Jane Garbutt, MB, ChB (1)

Results publications

PMID 21844413, PMID 22337680, PMID 28761581

NIH funding

U01AI064655 (1)